FIELD: biotechnology, veterinary science. SUBSTANCE: method involves the use of anatoxin isolated from enterotoxigenic strains of E. coli. Preparation is administrated parenterally 1-3 days before disease onset at the dose 0.5-2 ml. EFFECT: enhanced effectiveness of treatment. 3 tbl
Authors
Dates
1997-10-20—Published
1994-11-16—Filed